Quantinno Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Quantinno Capital Management’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-41,611	Closed	-$897K	–	3307
2025 Q4	$897K	Buy	41,611 +1,785	+4%	+$34.7K	﹤0.01%	1885
2025 Q3	$608K	Buy	39,826 +16,580	+71%	+$216K	﹤0.01%	1843
2025 Q2	$206K	Buy	23,246 +12,457	+115%	+$109K	﹤0.01%	2343
2025 Q1	$84.5K	Buy	+10,789	New	+$90.3K	﹤0.01%	2057

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Quantinno Capital Management's AVDL Position: Q1 2026 in Review

Quantinno Capital Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 41,611 shares — an estimated $897K sold.

Quantinno Capital Management first reported a position in AVDL in Q1 2025 and held it in 4 quarters. The position peaked at $897K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Quantinno Capital Management reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Quantinno Capital Management sold 41,611 Avadel Pharmaceuticals shares in Q1 2026, an estimated $897K.
Quantinno Capital Management first reported a position in Avadel Pharmaceuticals in Q1 2025 and held it in 4 quarters.
Quantinno Capital Management's Avadel Pharmaceuticals position peaked at $897K in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.